Press Releases Celcuity Inc.

Equities

CELC

US15102K1007

Market Closed - Nasdaq Other stock markets 01:30:00 25/06/2024 am IST			5-day change	1st Jan Change
16.66 ^USD	+4.58%		+14.03%	+14.34%

31/05	Needham Trims Price Target on Celcuity to $23 From $24, Maintains Buy Rating	MT
30/05	Sector Update: Health Care Stocks Mixed Pre-Bell Thursday	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Celcuity To Participate in Jefferies Global Healthcare Conference	04/06	AQ
Celcuity Announces Pricing of Underwritten Common Stock Offering	30/05	AQ
Celcuity Inc. Announces Plan to Initiate a Phase 3 Clinical Trial for Gedatolisib as First-Line Treatment for HR+/HER2- Advanced Breast Cancer and Secures Approximately $62 Million Debt Financing	30/05	AQ
Celcuity Inc. Reports First Quarter Financial Results and Provides Corporate Update	16/05	AQ
Celcuity Inc. Schedules Release of First Quarter 2024 Financial Results and Webcast/Conference Call	08/05	AQ
Celcuity To Present at Upcoming Needham and Stifel Investor Conferences	04/04	AQ
Celcuity Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	28/03	AQ
Celcuity Inc. Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Webcast/Conference Call	20/03	AQ
Celcuity to Participate in Leerink Partners Global Biopharma Conference 2024	06/03	AQ
Celcuity to Participate in Cowen’s 44th Annual Health Care Conference	28/02	AQ
Celcuity Announces First Patient Dosed in Phase 1b/2 CELC-G-201 Clinical Trial of Gedatolisib for the Treatment of Metastatic Castration Resistant Prostate Cancer	23/02	AQ
Celcuity Appoints Eldon Mayer as Chief Commercial Officer	20/02	AQ
Celcuity Presents Preclinical Data on Therapeutic Effects of Gedatolisib in Breast Cancer Models at the 2023 San Antonio Breast Cancer Symposium	06/12	AQ
Celcuity to Present Preclinical Data for Gedatolisib at the 2023 San Antonio Breast Cancer Symposium	01/12	AQ
Celcuity to Participate in the 6th Annual Evercore ISI HealthCONx Conference	22/11	AQ
Celcuity Inc. Reports Third Quarter 2023 Financial Results and Provides Corporate Updates	13/11	AQ
Celcuity Inc. Schedules Release of Third Quarter 2023 Financial Results and Webcast/Conference Call	06/11	AQ
Celcuity To Present at Upcoming Stifel and Jefferies Investor Conferences	01/11	AQ
Celcuity Inc. Announces $50 Million Private Placement	19/23/19	AQ
Celcuity : Science Day Presentation	22/23/22	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Celcuity Inc.

Equities

CELC

US15102K1007

Press Releases

Filters